Skinbiotherapeutics (LON:SBTX) Releases Quarterly Earnings Results

Skinbiotherapeutics (LON:SBTX) announced its earnings results on Tuesday. The company reported GBX (0.94) (($0.01)) EPS for the quarter, Digital Look Earnings reports.

Shares of LON:SBTX traded down GBX 0.12 ($0.00) during mid-day trading on Thursday, hitting GBX 15.38 ($0.20). 147,572 shares of the company traded hands, compared to its average volume of 261,826. The firm has a market cap of $19.78 million and a P/E ratio of -17.09. Skinbiotherapeutics has a 52-week low of GBX 12 ($0.16) and a 52-week high of GBX 26 ($0.34). The firm’s 50 day simple moving average is GBX 17.50 and its 200 day simple moving average is GBX 18.51.

Skinbiotherapeutics Company Profile

SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. It is developing pre-clinical product application, SkinBiotix, a cosmetic cream for skin health, as well as for applications in infection control and eczema. The company was formerly known as Skinbiotix Ltd.

Featured Article: Initial Coin Offerings entail a high degree of risk

Receive News & Ratings for Skinbiotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skinbiotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.